SCHEMBL8529795

SCHEMBL8529795

Clc1cc2c(cc1Cl)NCC2

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.52
DRD4 P21917 1/20 0.52
NOTUM Q6P988 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HTR2A P28223 4/20 0.41
HTR2C P28335 4/20 0.41
HTR2B P41595 4/20 0.41
PNMT P11086 1/20 0.39
F7 P08709 1/20 0.37
PARP1 P09874 1/20 0.37
F3 P13726 1/20 0.37
PARP10 Q53GL7 1/20 0.37
AR P10275 2/20 0.37
GFER P55789 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11015073 0.86 MAPT (0.44) DRD2DRD4NOTUMALDH1A1MAPT
SCHEMBL5827521 0.83 HTR2A (0.47) DRD2DRD4NOTUMALDH1A1MAPT
SCHEMBL30964480 0.83 HTR2A (0.47) DRD2DRD4NOTUMALDH1A1MAPT
SCHEMBL4138556 0.83 DRD2 (0.46) DRD2DRD4NOTUMALDH1A1MAPT
SCHEMBL8652483 0.83 DRD2 (0.55) DRD2DRD4NOTUMALDH1A1MAPT
SCHEMBL23384782 0.83 ALDH1A1 (0.53) DRD2DRD4NOTUMALDH1A1MAPT
SCHEMBL8526795 0.83 DRD2 (0.46) DRD2DRD4NOTUMALDH1A1MAPT
SCHEMBL8529890 0.83 DRD2 (0.46) DRD2DRD4NOTUMALDH1A1MAPT
SCHEMBL4496862 0.82 DRD2 (0.56) DRD2DRD4NOTUMALDH1A1MAPT
SCHEMBL22340168 0.78 HTR2C (0.53) DRD2DRD4MAPTHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2308872-A1 Heterocyclic derivatives as modulators of ion channels Vertex Pharmaceuticals Incorporated (US) 2011-04-13 EP disclosed
US-5834494-A SEROTONIN 5HT2B/2C RECEPTOR ANTAGONISTS; CNS NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDERS; IRRITABLE BOWEL SYNDROME SMITHKLINE BEECHAM P.L.C. (GB) 1998-11-10 US disclosed
EP-0707581-B1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-02-26 EP disclosed
CN-1129937-A Indoline derivatives as 5HT2C antagonists SMITHKLINE BEECHAM PLC (GB) 1996-08-28 CN disclosed
EP-0707581-A1 INDOLINE DERIVATIVES AS 5HT 2C? ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-04-24 EP disclosed
WO-1995001976-A1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-01-19 WO disclosed